Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00B42YS929
| Stock Name / Fund | iShares MSCI World GBP Hedged UCITS ETF (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | IGWD(GBX) LSE |
| ETF Ticker | IGWD.LS(GBX) CXE |
| ETF Ticker | IGWD.L(GBP) LSE |
Holdings detail for MRK
| Stock Name | Marks Electrical Group PLC |
| Ticker | MRK(GBX) LSE |
| TYPE | Common Stock |
| Country | UK |
| ISIN | GB00BM8Q5G47 |
| LEI | 2138007KN8TKPIXIQE92 |
| Ticker | MRK(EUR) F |
Show aggregate MRK holdings
News associated with MRK
- Surprising Analyst 12-Month Target For FDL
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
- IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
- Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
- (RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK)
said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
- Peter Lynch Detailed Fundamental Analysis - MRK
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
- Guru Fundamental Report for MRK - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
- Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
- MRK Factor-Based Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
- Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
- (RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
- Peter Lynch Detailed Fundamental Analysis - MRK
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
- Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
- The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
- Guru Fundamental Report for MRK - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
- MRK Factor-Based Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
- Peter Lynch Detailed Fundamental Analysis - MRK
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
- MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
- Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
- MRK Factor-Based Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
- MRK Quantitative Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
- iShares MSCI ACWI ETF Experiences Big Outflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
- Peter Lynch Detailed Fundamental Analysis - MRK
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
- Dow Movers: WMT, MRK
- In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value.
And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
- MRK Factor-Based Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
- After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
- The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
- Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
- (RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
- The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
- Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
- Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
- Peter Lynch Detailed Fundamental Analysis - MRK
- Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
- Top Analyst Reports for Merck, Palo Alto & Freeport
- Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
- Stocks See Support As Bessent Calls for a Big Rate Cut
- The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
- MRK April 2026 Options Begin Trading
- Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
- Stocks See Support As Bessent Calls for a Big Rate Cut
- The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
- Stocks See Support As Bessent Calls for a Big Rate Cut
- The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47
iShares MSCI World GBP Hedged UCITS ETF (Acc) MRK holdings
| Date | Number of MRK Shares Held | Base Market Value of MRK Shares | Local Market Value of MRK Shares | Change in MRK Shares Held | Change in MRK Base Value | Current Price per MRK Share Held | Previous Price per MRK Share Held |
|---|
| 2025-09-25 (Thursday) | 16,091 | USD 935,432 | USD 935,432 | 0 | USD -17,564 | USD 58.1339 | USD 59.2254 |
| 2025-09-24 (Wednesday) | 16,091 | USD 952,996 | USD 952,996 | | | | |
| 2025-09-18 (Thursday) | 16,091 | USD 967,977 | USD 967,977 | 0 | USD 12,141 | USD 60.1564 | USD 59.4019 |
| 2025-09-17 (Wednesday) | 16,091 | USD 955,836 | USD 955,836 | 0 | USD 379 | USD 59.4019 | USD 59.3783 |
| 2025-09-16 (Tuesday) | 16,091 | USD 955,457 | USD 955,457 | 0 | USD -3,952 | USD 59.3783 | USD 59.624 |
| 2025-09-15 (Monday) | 16,091 | USD 959,409 | USD 959,409 | | | | |
| 2025-09-12 (Friday) | 16,091 | USD 982,775 | USD 982,775 | | | | |
| 2025-09-11 (Thursday) | 16,091 | USD 1,010,546 | USD 1,010,546 | | | | |
| 2025-09-10 (Wednesday) | 16,091 | USD 997,843 | USD 997,843 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of MRK by Blackrock for IE00B42YS929
Show aggregate share trades of MRK| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-08-21 | BUY | 525 | 87.320 | 84.600 | 84.872 | GBX 44,558 | 67.51 |
| 2025-07-31 | SELL | -414 | 81.490 | 77.850 | 78.214 | GBX -32,381 | 67.79 Loss of -4,316 on sale |
| 2025-07-02 | BUY | 539 | 82.790 | 81.894 | 81.983 | GBX 44,189 | 68.44 |
| 2025-06-30 | BUY | 349 | 79.390 | 78.380 | 78.481 | GBX 27,390 | 68.58 |
| 2025-04-30 | BUY | 302 | 85.830 | 83.790 | 83.994 | GBX 25,366 | 72.62 |
| 2025-03-31 | BUY | 274 | | | 69.541* | | 75.45 |
| 2025-02-28 | BUY | 268 | 92.350 | 90.710 | 90.874 | GBX 24,354 | 76.61 |
| 2025-01-31 | SELL | -242 | 100.060 | 98.580 | 98.728 | GBX -23,892 | 79.50 Loss of -4,653 on sale |
| 2024-12-30 | BUY | 13,328 | 99.570 | 98.270 | 98.400 | GBX 1,311,475 | 79.71 |
| 2024-12-10 | BUY | 13,833 | 103.770 | 100.750 | 101.052 | GBX 1,397,852 | 79.73 |
| 2024-11-18 | BUY | 505 | 97.290 | 95.420 | 95.607 | GBX 48,282 | 79.76 |
| 2024-11-01 | SELL | -225 | 102.720 | 101.210 | 101.361 | GBX -22,806 | 80.90 Loss of -4,604 on sale |
| 2024-10-31 | SELL | -332 | 103.230 | 98.600 | 99.063 | GBX -32,889 | 81.06 Loss of -5,976 on sale |
| 2024-10-30 | SELL | -524 | 105.000 | 102.900 | 103.110 | GBX -54,030 | 81.13 Loss of -11,516 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of MRK
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 1,053,294 | 2,024 | 3,869,116 | 27.2% |
| 2025-09-18 | 1,184,922 | 8,005 | 3,015,340 | 39.3% |
| 2025-09-17 | 1,616,768 | 18,730 | 3,647,853 | 44.3% |
| 2025-09-16 | 1,223,711 | 960 | 3,598,709 | 34.0% |
| 2025-09-15 | 1,814,767 | 8,420 | 4,295,962 | 42.2% |
| 2025-09-12 | 2,018,463 | 7,557 | 3,506,694 | 57.6% |
| 2025-09-11 | 1,493,728 | 5,399 | 3,180,828 | 47.0% |
| 2025-09-10 | 2,013,102 | 5,335 | 3,313,847 | 60.7% |
| 2025-09-09 | 1,075,137 | 5,505 | 2,373,817 | 45.3% |
| 2025-09-08 | 2,147,204 | 2,448 | 3,731,343 | 57.5% |
| 2025-09-05 | 1,440,114 | 9,948 | 2,983,296 | 48.3% |
| 2025-09-04 | 1,439,726 | 1,121 | 5,661,887 | 25.4% |
| 2025-09-03 | 1,849,103 | 3,553 | 4,699,607 | 39.3% |
| 2025-09-02 | 2,193,136 | 115,135 | 4,314,826 | 50.8% |
| 2025-08-29 | 1,545,057 | 11,420 | 3,841,715 | 40.2% |
| 2025-08-28 | 1,559,766 | 6,169 | 5,284,888 | 29.5% |
| 2025-08-27 | 1,383,476 | 7,838 | 3,737,506 | 37.0% |
| 2025-08-26 | 1,328,235 | 1,229 | 2,869,944 | 46.3% |
| 2025-08-25 | 2,177,200 | 5,578 | 3,771,313 | 57.7% |
| 2025-08-22 | 1,523,352 | 7,497 | 3,248,575 | 46.9% |
| 2025-08-21 | 2,449,660 | 18,540 | 5,416,969 | 45.2% |
| 2025-08-20 | 1,189,291 | 16,692 | 3,133,345 | 38.0% |
| 2025-08-19 | 1,722,651 | 2,331 | 3,737,689 | 46.1% |
| 2025-08-18 | 1,150,937 | 2,822 | 2,604,344 | 44.2% |
| 2025-08-15 | 1,795,394 | 1,673 | 3,415,808 | 52.6% |
| 2025-08-14 | 2,198,562 | 2,272 | 4,496,398 | 48.9% |
| 2025-08-13 | 1,885,480 | 19,537 | 3,953,045 | 47.7% |
| 2025-08-12 | 1,593,844 | 10,360 | 3,185,667 | 50.0% |
| 2025-08-11 | 990,405 | 3,605 | 2,886,690 | 34.3% |
| 2025-08-08 | 1,224,378 | 11,187 | 2,672,279 | 45.8% |
| 2025-08-07 | 1,718,661 | 5,356 | 4,504,850 | 38.2% |
| 2025-08-06 | 2,028,927 | 1,882 | 4,007,252 | 50.6% |
| 2025-08-05 | 1,573,681 | 6,049 | 3,579,534 | 44.0% |
| 2025-08-04 | 1,568,975 | 944 | 3,301,801 | 47.5% |
| 2025-08-01 | 1,718,701 | 13,853 | 4,079,642 | 42.1% |
| 2025-07-31 | 3,367,755 | 2,664 | 6,082,644 | 55.4% |
| 2025-07-30 | 2,253,458 | 5,878 | 4,162,636 | 54.1% |
| 2025-07-29 | 5,939,072 | 36,249 | 11,111,795 | 53.4% |
| 2025-07-28 | 2,243,235 | 6,739 | 4,563,913 | 49.2% |
| 2025-07-25 | 1,302,437 | 6,900 | 2,889,207 | 45.1% |
| 2025-07-24 | 1,156,397 | 2,570 | 2,732,351 | 42.3% |
| 2025-07-23 | 1,879,400 | 20,280 | 4,001,025 | 47.0% |
| 2025-07-22 | 1,628,754 | 1,773 | 3,592,847 | 45.3% |
| 2025-07-21 | 1,900,563 | 12,571 | 5,188,432 | 36.6% |
| 2025-07-18 | 1,536,762 | 1,246 | 3,463,059 | 44.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.